BD, LabCorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics
Companies combine key capabilities to advance flow cytometry as an essential companion diagnostic modality for cancer and other diseases BD (Becton, Dickinson and Company) (NYSE: B...
Read →